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Volume 58, Number 2 Abstracts 565(BM) balloon expandable stents in the treatment of common iliac artery
disease. This study was performed to evaluate midterm outcomes of bare
metal vs covered balloon expandable stents for treatment of aortoiliac
(AI) occlusive disease.
Methods: All AI endovascular interventions for symptomatic periph-
eral arterial occlusive disease performed at a single institution from 2006-
2012 were reviewed. Patients that underwent stent placement in the
common iliac arterial segment were included in the analysis. Demographic
data, TransAtlantic Inter-Societal Classiﬁcation (TASC), stent type, patency,
and all reinterventions for each limb were compared.
Results: 188 procedures in 124 patients were performed for treat-
ment of de novo distal aorta and/or common iliac artery stenosis. Bare
metal balloon expandable stents were used in 135 arteries, and covered
balloon expandable stents were used in 53 arteries. There was no difference
in age, gender, or TASC classiﬁcation between the two groups. Table I.
Median follow up was 1.7 years (IQR, 0.6-3.0). There was no difference
in overall primary or primary assisted patency between the two groups.
Table II. Secondary patency was signiﬁcantly better in the covered stent
group, however, common Iliac arteries treated with covered stents were
more likely at 1 year and beyond to require repeat aortoiliac intervention
(HR, 2.6; 95% CI, 1.13-6.0; P ¼ .02; Fig). TASC classiﬁcation did not
predict need for reintervention in either group.
Conclusions: In the current study, covered stents have improved
secondary patency over bare metal stents for treatment of AI occlusive
disease, at the expense of increased reinterventions. The difference in
secondary patency may be due to more focal, edge restenosis in covered
stents vs diffuse restenosis in bare metal stents.
Fig.
Table I. Demographic characteristics of treated lesions
Overall Bare metal Covered P valueAge (mean 6 SD) 64 6 11 64 6 12 65 6 11 .5
TASC A (%) 54 (45) 39 (43) 15 (52) .57
TASC B 56 (30) 41 (30) 15 (28) .99
TASC C 41 (22) 30 (22) 11 (21) .98
TASC D 36 (19) 24 (18) 12 (23) .58Table II. Patency of treated lesions
n ¼ 188 Overall Bare metal Covered P valuePrimary patency (%) 121 (75) 86 (75) 35 (74) .99
Primary assisted patency 136 (84) 93 (82) 43 (91) .18
Secondary patency 140 (87) 94 (82) 46 (98) .02The Diagnostic Triad of Orphan Heel Syndrome: Posterior Tibial and
Peroneal Artery Occlusive Disease, Poorly Controlled Diabetes, and
Renal Failure
Zack Taylor Sr, MD. Vascular Surgery, University of Arizona, Tucson, Ariz
Objectives: Large heel ulcers represent enormous challenges. Limb
preservation is difﬁcult in these patients, who often suffer from diabetes,
renal failure and calciﬁed, distal arterial occlusive disease. Traditional non-
invasive studies including ankle-brachial indices and toe-pressures may not
accurately predict healing. The purpose of this study was to assess the valueof traditional noninvasive studies, limb salvage rate and healing time in
patients with full thickness heel ulcers.
Methods: From 2009-2011, a single interdisciplinary limb salvage unit
evaluated 21 consecutive patients with deep heel ulcers requiring operative
debridement. Pertinent comorbidities including diabetes and renal insufﬁ-
ciency were noted. Investigators blinded to the clinical course reviewed all
studies. Wound healing times and limb salvage rates were calculated.
Results: Among the 21 patients, 10 (48%) had CKD (7 on dialysis; 3
Stage 3/4 CKD); 18/21 (86%) were known diabetics at the time of presen-
tation; all patients had HgbA1c > 9 and in 8/21, HgbA1c exceeded 11.
Serum albumin levels were uniformly low (range, 1.4-4). 66.7% had normal
ABIs (range, 0.8-1.2). ABIs were noncompressible in 23.8% of patients.
Only two patients had low ABIs (0.28 and 0.39). Healing occurred in 13/
21 patients over a mean of 251 days (range, 42-540); the remainder died
of comorbidities before healing (1), underwent major amputation (3), or
were lost to follow up (4). ABIs and TPs did not correlate with healing. Eight
patients with normal forefoot perfusion by noninvasive testing had severe heal
malperfusion by angiography; 53% (10) patients underwent angiography and
7 underwent revascularization, primarily endovascular.
Conclusion: In this patient group, the heel is frequently ischemic even
in the presence of a palpable DP pulse and normal forefoot noninvasive
testing. This is due to an unusual pattern of occlusive disease that dispropor-
tionately involves the posterior tibial and pedal arch vessels, (the heel circula-
tion is compartmentalized from the forefoot) a condition termed orphan heel
syndrome. It is also associated with uncontrolled diabetes and renal failure.
Even with aggressive care, healing times are prolonged. Early angiography
and heel revascularization is recommended in functional patients with this
clinical triad.
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popliteal Artery to Enhance Clinical Efﬁcacy Following Endovascular
Revascularization: A Proof of Concept First in Man Study
Christopher D. Owens,1 Warren Gasper,1 Hugh F. Alley,1 Karen C.
Chong,1 Joseph H. Rapp,1 Michael S. Conte,1 Kirk Seward,2 Marlene S.
Grenon1. 1University of California, San Francisco, San Francisco, Calif;
2Mercator MedSystems, San Leandro, Calif
Objectives: Restenosis following peripheral intervention is in part an
inﬂammatory disease. We hypothesize that a non-stent-based local drug
delivery of the anti-inﬂammatory corticosteroid dexamethasone (DEX)
would mitigate intervention-associated inﬂammation and thus improve
long-term arterial patency.
Methods: This was an investigator initiated pilot study to determine if
percutaneous adventitial drug delivery was safe and feasible in human
peripheral arteries. Following successful intervention, an adventitial micro-
infusion catheter (MIC) was advanced over a 0.014” wire to the treated
segment. Its micro-needle was deployed into the adventitia to deliver
DEX (4 mg/mL) mixed with contrast agent providing ﬂuoroscopic visual-
ization. The safety outcome was freedom from vessel dissection, thrombosis
or extravasation, while the primary efﬁcacy outcome was duplex-determined
binary restenosis deﬁned as PSVR >2.4 of the treated segment.
Results: 21 patients with Rutherford classiﬁcation 2-5 enrolled in this
study and followed for a median of 335 days. Mean age was 65.9 and 57.1%
were diabetic. Treated lesion length was 8.7 6 5.2 cm and 48% were
chronic total occlusions. 80% of treated lesions were in the distal SFA/popli-
teal artery. The average preoperative Rutherford score was 3.77 6 .8. All
lesions were treated by balloon angioplasty with provisional stenting for
suboptimal result. 11.5 6 5.7 mg of dexamethasone was injected into the
adventitia of the treated lesions. There was 100% technical success of
drug delivery and no procedural or drug-related adverse events. Rutherford
score at last available follow-up was .466 .74 (P < .001) and ABI improved
from .68 6 .15 to .95 6.18 (P < .001). Postprocedural C-reactive protein
(CRP) was not signiﬁcantly different from baseline CRP (P ¼ .13). Two
patients developed binary restenosis of the index lesion during the follow-
up period.
Conclusions: Adventitial drug delivery via the MIC is a safe and
feasible alternative to intimal-based methods. These preliminary data suggest
that perivascular DEX treatment may improve outcomes following angio-
plasty to the distal femoro-popliteal segment. Further study is warranted to
establish efﬁcacy for anti-inﬂammatory treatment following angioplasty.
Demographic and Echocardiographic Predictors of Anatomic Site and
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Objectives: The association between demographic and echocardio-
graphic ﬁndings with the site of cardiogenic peripheral embolization is
